Aglatimagene besadenovec

Aglatimagene besadenovec is a gene pharmaceutical. It is currently being investigated in clinical studies.

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

7392 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Prostatic neoplasms	D011471	—	C61	1077	1960	586	109	2600	5882
Prostatic hyperplasia	D011470	EFO_0000284	N40	32	70	83	70	378	616
Castration-resistant prostatic neoplasms	D064129	—	—	239	299	52	13	82	584
Neoplasms	D009369	—	C80	196	146	39	2	175	499
Hyperplasia	D006965	EFO_0000536	—	23	45	59	43	321	479
Adenocarcinoma	D000230	—	—	81	194	37	4	157	440
Breast neoplasms	D001943	EFO_0003869	C50	93	43	13	5	116	251
Neoplasm metastasis	D009362	EFO_0009708	—	36	66	23	10	56	174
Carcinoma	D002277	—	C80.0	57	74	8	2	39	167
Lower urinary tract symptoms	D059411	EFO_0008008	—	7	21	18	11	100	152

Show 89 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Lung neoplasms	D008175	—	C34.90	43	21	5	—	51	113
Ovarian neoplasms	D010051	EFO_0003893	C56	56	25	2	—	23	90
Renal cell carcinoma	D002292	EFO_0000376	—	36	17	1	—	25	70
Head and neck neoplasms	D006258	—	—	21	9	1	—	30	57
Liver neoplasms	D008113	EFO_1001513	C22.0	14	7	2	—	18	40
Uterine cervical neoplasms	D002583	—	—	15	11	1	—	17	37
Sarcoma	D012509	—	—	14	7	1	—	15	34
Endometrial neoplasms	D016889	EFO_0004230	—	21	12	1	—	7	33
Small cell lung carcinoma	D055752	—	—	21	16	1	—	4	33
Lymphoma	D008223	—	C85.9	17	3	1	—	11	31

Show 78 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Pancreatic neoplasms	D010190	EFO_0003860	C25	39	19	—	—	25	71
Kidney neoplasms	D007680	EFO_0003865	C64	16	8	—	—	29	49
Stomach neoplasms	D013274	EFO_0003897	C16	20	8	—	—	12	37
Colonic neoplasms	D003110	—	C18	15	4	—	—	17	35
Esophageal neoplasms	D004938	—	C15	12	10	—	—	17	34
Circulating neoplastic cells	D009360	—	—	1	3	—	—	28	32
Glioblastoma	D005909	EFO_0000515	—	13	9	—	—	10	26
Rectal neoplasms	D012004	—	—	5	5	—	—	17	26
Triple negative breast neoplasms	D064726	—	—	18	9	—	—	—	22
Glioma	D005910	EFO_0000520	—	11	4	—	—	6	20

Show 167 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Anxiety	D001007	EFO_0005230	F41.1	1	—	—	—	9	10
Male breast neoplasms	D018567	—	—	7	—	—	—	2	9
Diabetes mellitus	D003920	EFO_0000400	E08-E13	2	—	—	—	7	9
Positron emission tomography computed tomography	D000072078	—	—	4	—	—	—	5	9
Sedentary behavior	D057185	—	—	1	—	—	—	7	8
Intestinal neoplasms	D007414	—	C26.0	4	—	—	—	2	6
Venous thromboembolism	D054556	EFO_0004286	I74	1	—	—	—	4	5
Skin neoplasms	D012878	EFO_0004198	C44	1	—	—	—	3	4
Pleural effusion	D010996	—	J90	2	—	—	—	2	4
Nasopharyngeal carcinoma	D000077274	—	—	2	—	—	—	2	4

Show 58 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Depression	D003863	—	F33.9	—	—	—	—	11	11
Genetic predisposition to disease	D020022	—	—	—	—	—	—	8	8
Sarcopenia	D055948	EFO_1000653	M62.84	—	—	—	—	5	5
Sleep initiation and maintenance disorders	D007319	—	F51.01	—	—	—	—	5	5
Hyperthermia	D000084462	—	—	—	—	—	—	5	5
Ejaculatory dysfunction	D000097910	—	N53.1	—	—	—	—	5	5
Spinal anesthesia	D000775	—	—	—	—	—	—	4	4
Overweight	D050177	—	E66.3	—	—	—	—	4	4
Hiv infections	D015658	EFO_0000764	B20	—	—	—	—	4	4
Urethral obstruction	D014524	—	—	—	—	—	—	4	4

Show 339 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	Aglatimagene besadenovec
INN	aglatimagene besadenovec
Description	Aglatimagene besadenovec is a gene pharmaceutical. It is currently being investigated in clinical studies.
Classification	Gene
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—